Ostarine, also known by its chemical names MK-2866, Enobosarm, or M2, is a Selective Androgen Receptor Modulator (SARM). SARMs are compounds designed to selectively bind to androgen receptors in the body, influencing the signaling pathways to promote anabolic (muscle-building) effects without causing the same level of androgenic (masculinizing) side effects associated with anabolic steroids.
Ostarine has been studied for its potential use in treating conditions such as muscle wasting and osteoporosis. It is believed to have a high affinity for androgen receptors in muscle and bone tissues, which could lead to increased muscle mass and bone density.
As of my last knowledge update in January 2022, Ostarine is not approved for medical use in many countries, and its safety and long-term effects are still being studied. In the fitness and bodybuilding communities, Ostarine has gained popularity as a performance-enhancing substance.
It's important to note that the use of Ostarine and other SARMs has raised concerns about potential misuse and side effects. If you are considering the use of Ostarine or any similar compound, it's crucial to consult with a healthcare professional. Misuse or improper use of such substances can have adverse effects on health, and their use is often associated with potential legal and ethical issues. Additionally, the regulatory status of these substances may vary by jurisdiction.
Product Name: | Ostarine(MK-2866) |
Synonyms: | (2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide;((2s)-3-(4-cyanophenoxy)-N-[4-cyano-3-(trifluoroMethyl)phenyl]-2-hydroxy-2-MethylpropanaMide);Ostarine (MK-2866, GTx-024);Ostarine(MK-2866);(2S)-3-(4-cyano-2,3,5,6-tetradeuteriophenoxy)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide;MK-2866 MK-2866 White powder 99%;Factory Supply best quality Ostarine(MK-2866) 1202044-20-9 CAS NO.1202044-20-9;Ostarine(MK-2866),mk2866,mk 2866 |
CAS: | 1202044-20-9 |
MF: | C19H14F3N3O3 |
MW: | 389.33 |
Use | Ostarine, also known as ostarine MK-2866, is an investigational selective androgen receptor modulator (SARM) developed by GTx, Inc. for the treatment of conditions such as muscle wasting and osteoporosis. |
Description | Ostarine is an investigational drug that has not yet been approved by the US Food and Drug Administration (FDA). It is part of a class of drugs called selective androgen receptor modulators (SARMs). |
Uses | (2S)-3-(4-Cyanophenoxy-2,3,5,6-d4)-N-[4-cyano-3-(trifluoromethyl)phenyl]-2-hydroxy-2-methylpropanamide is a metabolites of selective androgen receptor modulators (SARM). |